Alaunos Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Alaunos Therapeutics, Inc. filed an S-1 for the resale of shares by Mast Hill Fund, L.P., outlining a potential $25 million equity financing and its strategic pivot to a preclinical oral obesity program.